Home › Funds › BVF INC/IL › STOK

BVF INC/IL position in STOK

STOKE THERAPEUTICS INC · Health Care

BVF INC/IL reported holding 2,547,557 shares of STOK (STOKE THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$83.4M, representing 2.13% of its reported portfolio and ranking #17 among its reported holdings. BVF INC/IL has disclosed STOK holdings in 4 of the last 4 reported quarters, going back to Q3 2025.

Latest position (Q2 2026)2.55M sh
Reported value held$83.36M
Portfolio Weight2.13%
First reportedQ3 2025
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How BVF INC/IL's STOK position evolved

BVF INC/IL first disclosed a stake in STOK in Q3 2025 at 1,657,096 shares (US$38.9M). The position peaked in Q2 2026 at 2,547,557 shares, worth US$83.4M. Across 4 filings, BVF INC/IL increased the stake 2 time(s), trimmed it 0 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 2,547,557 shares valued at US$83.4M. Notable position changes include a 37% increase in Q4 2025 (shares rose 3% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2025 1.66M $38.94M New
Q4 2025 2.27M $71.91M Add
Q1 2026 2.55M $82.95M Add
Q2 2026 2.55M $83.36M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About STOK and 13F data

STOK (STOKE THERAPEUTICS INC) is a Health Care company. 52 other funds we track also report a position in STOK — the largest reported positions include RTW INVESTMENTS, LP (US$184.0M), Lynx1 Capital Management LP (US$132.1M), Redmile Group, LLC (US$129.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding STOK

All STOK fund holders →

FAQ

How long has BVF INC/IL held STOK?

BVF INC/IL has disclosed STOK holdings in 4 of the last 4 reported quarters, going back to Q3 2025.

What is BVF INC/IL's current position in STOK?

As of Q2 2026, BVF INC/IL holds 2.55M shares of STOK (STOKE THERAPEUTICS INC), valued at $83.36M, representing 2.13% of its reported portfolio and ranking #17.

Has BVF INC/IL been buying or selling STOK?

In the latest 13F filing (Q2 2026), BVF INC/IL held unchanged its position in STOK. The position peaked in Q2 2026 at 2.55M shares.

Which other funds hold STOK?

Other major institutional holders of STOK include RTW INVESTMENTS, LP, Lynx1 Capital Management LP, Redmile Group, LLC, among 52 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.